Summit Therapeutics Inc

SMMTNASDAQ · USD
16.39USD0.00 (+5.88%)
125

Summit Therapeutics Inc (SMMT) Option Chain

As of September 29, 2026, Summit Therapeutics Inc is trading at $16.39, a +5.88% change from the previous close. The nearest expiration is Oct 2, 2026. Implied volatility is 113.8%. IV Rank is 67%.

Read more

Tracking the SMMT option chain helps you see every strike and expiry on Summit Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Summit Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of SMMT options activity at a glance. Use our scanner to monitor the SMMT option chain in real time and filter for the SMMT options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For SMMT stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the SMMT option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where SMMT stock options are being actively traded and where they are not.

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae.

The company was founded in 2003 and is based in Cambridge, Massachusetts.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Summit Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen SMMT options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of SMMT stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile53.97% Neutral
  • Market cap (M$)13,075
  • 52 weeks high-43.93%
  • 52 weeks low35.79%
  • Analyst recommendationBuy
    1.67
  • Target price$29.78
    81.70% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-10-19
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.12
  • EPS growth next 5 years23.53%

As of September 29, 2026

2026-10-02
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
53.2780840.780.890.952.4015.50+0.130.601.900.001.2578652546.73
61.41561040.530.390.301.5516.00+3.361.152.300.001.734121,15738.59
68.84963911.100.000.152.0516.50+6.591.603.300.112.34132831.16
75.397415150.880.000.451.3017.00+9.820.854.700.612.17010024.61
80.97497590.930.000.401.4517.50+13.051.804.001.111.7902319.03

As of September 29, 2026

Scan the full option chain in one place

Browse the full SMMT option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial